Affiliation:
1. LBYP College of Pharmacy, Pathri, Chh. Sambhaji Nagar, Maharashtra, India
Abstract
The most frequent cause of dementia, Alzheimer’s disease, is a major global health concern that affects both individuals and society as a whole. This overview first discusses the current state of knowledge regarding the epidemiology, genetics, pathology, and pathophysiology of Alzheimer’s disease before moving on to the disease’s clinical manifestation and available treatments. Lastly, the article explores how novel therapeutic approaches are being developed with the goal of shifting from treatment to prevention in light of our growing understanding of Alzheimer aetiology, which includes the identification of a prolonged
preclinical phase.
Reference20 articles.
1. Alzheimer Europe. Dementia in Europe Yearbook 2019: estimating the prevalence of dementia in Europe. 2020. https://www.alzheimereurope.org/content/download/19 5515/1457520/file/FINAL%2005707%20 Alzheimer%20Europe%20yearbook%20201 9.pdf (accessed Jan 24, 2021).
2. Scheltens P, Blennow K, Breteler MM, et al. Alzheimer’s disease. Lancet 2016; 388: 505–17.
3. Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6: 734–46.
4. Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005; 366: 2112–17.
5. Mayeux R. Epidemiology of neurodegeneration. Annu Rev Neurosci 2003; 26: 81–104.